Skip to main
VIVO
VIVO logo

Meridian Bioscience (VIVO) Earnings Dates & Reports

Meridian Bioscience (VIVO) Most Recent Earnings

Report DateNov 22, 2022
Period EndingQ4 2022
Est. EPS$0.15
Actual EPS$0.20
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Meridian Bioscience (VIVO) Earnings per Share (EPS) History

Signup for full access
Browse free

Meridian Bioscience (VIVO) Latest Earnings

The value each VIVO share was expected to gain vs. the value each share gained.

Meridian Bioscience (VIVO) reported its most recent earnings on Nov 22, 2022 for Q4 2022, posting earnings per share (EPS) of $0.20. This exceeded analysts' expectations of $0.15 by 33.33%, marking a Beat.

For comparison, Meridian Bioscience reported EPS of $0.23 in the same quarter last year.

The company is expected to announce its next earnings report on 11/22/2022, with analysts projecting an EPS of $0.

Meridian Bioscience (VIVO) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2022Nov 22, 2022
$0.15$0.20+33.33%
DeckReportListen
Q3 2022Aug 5, 2022
$0.16$0.160.00%
DeckReportListen
Q2 2022May 6, 2022
$0.47$0.66+40.43%
DeckReportListen
Q1 2022Feb 4, 2022
$0.25$0.35+40.00%
DeckReportListen
Q4 2021Nov 12, 2021
$0.20$0.23+15.00%
DeckReportListen
View all

Meridian Bioscience (VIVO) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Meridian Bioscience’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 5, 2022
May 6, 2022
Feb 4, 2022
Nov 12, 2021

Meridian Bioscience (VIVO) Earnings FAQs

Meridian Bioscience (VIVO) last reported earnings on Nov 22, 2022 for Q4 2022, posting an EPS of $0.20, which Beat the estimate of $0.15 by 33.33%.

For Q4 2022, Meridian Bioscience (VIVO) reported an EPS of $0.20, exceeding analysts' estimate of $0.15 by 33.33%.

For Q4 2022, Meridian Bioscience (VIVO) Beat expectations with an actual EPS of $0.20 vs. an estimated EPS of $0.15.

Following the last earnings report on Nov 22, 2022, Meridian Bioscience (VIVO)'s stock price moved — from — to —.

The next Meridian Bioscience (VIVO) earnings call is scheduled for Nov. 22, 2022, where executives will discuss financial results and outlook.

Meridian Bioscience (VIVO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.